Identity
- Trade Name
- INFINITI® CYP2C19 Intellipac® Reagent Module FDA UDI
- Generic Name
- Cytochrome P450 (CYP450) gene polymorphism IVD, kit, multiplex FDA UDI
- Device Name
- CYP2C19 drug metabolyzing enzyme genotyping system FDA UDI
- Model / Reference
- 03-2220-01 FDA UDI
- Description
- CYP2C19 drug metabolyzing enzyme genotyping system FDA UDI
Identifiers
- Catalog Number
- 03-2220-01 FDA UDI
- Primary DI / UDI-DI
- 00850009370143 FDA UDI
- FDA Product Code
- NTI FDA UDINSU FDA UDI
- GMDN Term
- Cytochrome P450 (CYP450) gene polymorphism IVD, kit, multiplex FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 862.3360 FDA UDI862.2570 FDA UDI
- Commercial Distribution
- Not in Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
INFINITI® CYP2C19 Intellipac® Reagent Module by Autogenomics, Inc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Autogenomics, Inc
Sources (1)
- FDA UDI d5df2aff-5a1c-4357-b5d4-8bb5499ee511 37 fields · synced May 30, 2026